Operating Lease, Liability, Current of Rubius Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2022
- Taxonomy & unit
- us-gaap: USD
- Description
- Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
- Summary
-
Rubius Therapeutics, Inc. quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Dec 2018 to 31 Dec 2022.
- Rubius Therapeutics, Inc. Operating Lease, Liability, Current for the quarter ending 31 Dec 2022 was $1,100,000, a 88% decline year-over-year.
- Source SEC data
- View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)
Rubius Therapeutics, Inc. Quarterly Operating Lease, Liability, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2022 | $1,100,000 | -$7,915,000 | -88% | 31 Dec 2022 | 10-K | 27 Feb 2023 | 2022 | FY |
| Q3 2022 | $9,212,000 | +$392,000 | +4.4% | 30 Sep 2022 | 10-Q | 09 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $9,149,000 | +$312,000 | +3.5% | 30 Jun 2022 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $9,082,000 | +$185,000 | +2.1% | 31 Mar 2022 | 10-Q | 10 May 2022 | 2022 | Q1 |
| Q4 2021 | $9,015,000 | +$70,000 | +0.78% | 31 Dec 2021 | 10-K | 27 Feb 2023 | 2022 | FY |
| Q3 2021 | $8,820,000 | -$899,000 | -9.2% | 30 Sep 2021 | 10-Q | 08 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $8,837,000 | -$672,000 | -7.1% | 30 Jun 2021 | 10-Q | 09 Aug 2021 | 2021 | Q2 |
| Q1 2021 | $8,897,000 | -$536,000 | -5.7% | 31 Mar 2021 | 10-Q/A | 20 Aug 2021 | 2021 | Q1 |
| Q4 2020 | $8,945,000 | -$1,595,000 | -15% | 31 Dec 2020 | 10-K | 27 Feb 2023 | 2022 | FY |
| Q3 2020 | $9,719,000 | +$2,721,000 | +39% | 30 Sep 2020 | 10-Q | 09 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $9,509,000 | +$4,433,000 | +87% | 30 Jun 2020 | 10-Q | 10 Aug 2020 | 2020 | Q2 |
| Q1 2020 | $9,433,000 | +$4,908,000 | +108% | 31 Mar 2020 | 10-Q | 11 May 2020 | 2020 | Q1 |
| Q4 2019 | $10,540,000 | +$6,038,000 | +134% | 31 Dec 2019 | 10-K | 25 Feb 2022 | 2021 | FY |
| Q3 2019 | $6,998,000 | 30 Sep 2019 | 10-Q | 14 Nov 2019 | 2019 | Q3 | ||
| Q2 2019 | $5,076,000 | 30 Jun 2019 | 10-Q | 13 Aug 2019 | 2019 | Q2 | ||
| Q1 2019 | $4,525,000 | 31 Mar 2019 | 10-Q | 15 May 2019 | 2019 | Q1 | ||
| Q4 2018 | $4,502,000 | 31 Dec 2018 | 10-Q | 14 Nov 2019 | 2019 | Q3 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.